Endo Pharmaceuticals (ENDP) Tops Q4 EPS by 10c; Increases FY11 Outlook
Tweet Send to a Friend
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) reported Q4 EPS of $1.06, $0.10 better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
